INS and Insulin resistance: Aspalathin has been shown to ameliorate insulin resistance by enhancing insulin signaling via protein kinase B (AKT) and 5′-Adenosine monophosphate-activated protein kinase (AMPK) activation and by reducing inflammation via protein kinase C (PKC) and nuclear factor-κB (NFκB) pathways.